Communicable disease policy development in response to changing European political frontiers in Finland,Norway and Sweden

Abstract

Aims: The European Union (EU) enlargement of 2004 brings both opportunities and challenges for public health. It is believed that further integration will bring direct health benefits, mainly through improved socioeconomic conditions, but there are also risks associated with the EU expansion, in particular cross-border health risks, such as the impact of the internal EU market policy of free movement and migration on communicable disease patterns. Against this background, this article examines communicable disease policy development in Finland, Norway and Sweden in response to changing European political frontiers, in particular the EU accession of the Baltic States. The emphasis is on HIV/AIDS and tuberculosis. Methods: The study is based on a qualitative and quantitative approach, using two complementary methods: documentary analysis and stakeholder analysis. Results: The article identifies a distinct pattern in communicable disease policy development between 1990 and 2005. The turn of the new millennium saw a sharp increase in national attention and the priority assigned to communicable diseases in Finland, Norway and Sweden. The article argues that this development is likely to be related to the rising national, regional and European awareness of the public health challenges associated with communicable diseases in today's borderless Europe. It also shows that the Baltic health situation is a particular concern for Finland. Conclusions: Although there is increasing national and regional activity within the communicable disease area, there is a need for a more effective European approach to tackle the future communicable disease challenges that may follow in an increasingly interdependent and integrated Europe.

Keywords

Baltic States communicable diseases communicable disease policy cross-border movement European Economic Area European Union Finland migration Norway Sweden

Get full access to this article

View all access options for this article.

References

Lock K. , McKee M.

Health impact assessment: assessing opportunities and barriers to intersectoral health improvement in an expanded

European Union. J Epidemiol Community Health 2005;59:356-60.

Dodgson R. , Lee K. , Drager N. Global health governance: A conceptual review. London: Centre on Global Change and Health, London School of Hygiene and Tropical Medicine/ World Health Organization; 2002.

Cucic S. European Union Health policy and its implications for national convergence . Int J Qual Health Care 2000;12:217-25.

Birtwistle T. Principles of European Union law. Leeds: Liverpool Academic Press; 2003.

Rowe L. , Rechel B. Fighting tuberculosis and HIV/AIDS in Northeast Europe: sustainable collaboration or political rhetoric. Eur J Public Health 2006;16:609-14.

Honneland G. , Rowe L. Health as International politics: combating communicable diseases in the Baltic Sea region. Aldershot: Ashgate; 2004.

Jacab Z. What role can European health policy play in conflict prevention? In: Mellbourn A , editor. Health and conflict prevention. Hedemora: Gidlunds förlag; 2006. p 24-30.

European Commission. Proposal for a Regulation of the European Parliament and of the Council: establishing a European Centre (for Disease Prevention and Control), COM (2003)441 final/2 Brussels;. Available at: http://www.evm-vaccines.org/pdfs/europarl_regulation_prevention.pdf (accessed 20 February 2007), 2003.

Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia Available at: http://www.aidsactioneurope.org/fileadmin/dl/uk/downloads/dublindeclaration_eng.pdf (accessed 10 February 2007), 2004.

10.

Vilnius Declaration on Measures to Strengthen Reponses to HIV/AIDS in the European Union and in Neighbouring Countries; Available at: http://ec.europa.eu/archives/commission_1999_2004/telicka/vilnius_press_en.pdf (accessed 20 February 2007), 2004.

11.

European Commission. Communication from the Commission to the Council and the European Parliament on Combating HIV/AIDS within the European Union and in the Neighbouring Countries 2006-2009, COM (2005)654final. Brussels; Available at: http://ec.europa.eu/health/ph_threats/com/aids/docs/com_2005_654_en.pdf (accessed 20 October 2007), 2005.

12.

Rhodes T. , Ball A. , et al. HIV infection associated with drug injecting in the newly independent states, Eastern Europe: the social and economic context of epidemics. Addiction 1999 ;94:1323-36.

13.

Blystad H. , Berglund T. , Aavitsland P. , Gundersen VR

Spread of gonorrhoea from the Barents and Baltic Sea regions to the Nordic countries?

Euro Surveill Weekly 2002;6.

14.

Liitsola K. , Ristola M. , Holmstrom P. , Salminen M. , Brummer-Korvenkontio H. , Simola S. , Suni J. An HIV-1 outbreak among Finnish IDUs: caused by the circulating recombinant from AE. In13th International AIDS Conference, Durban, South Africa, 2000.

15.

Löytonen M. , Maasilta P. Multi-drug resistant tuberculosis in Finland - a forecast. Soc Sci Med 1998;46:695-702.

16.

Organization for Economic Co-operation and Development. Trends in international migration: Annual Report 2003. Paris: OECD; 2003.

17.

Baldwin P. Disease and democracy: the industrialized world faces AIDS. London: University of California Press; 2005.

18.

Collin J. , Lee K. Globalisation and transborder health risks in the UK. Case studies in tobacco control and population mobility. London: Nuffield Trust; 2003.

19.

Reintjes R. , Thelen M. , Reiche R. , Csohán A. Benchmarking National surveillance systems: a new tool for the comparison of communicable disease surveillance and control in Europe. Eur J Public Health 2007;17:375-80.